CHEBI:31536 - emtricitabine

ChEBI IDCHEBI:31536
ChEBI Nameemtricitabine
Stars
DefinitionAn organofluorine compound that is 5-fluorocytosine substituted at the 1 position by a 2-(hydroxymethyl)-1,3-oxathiolan-5-yl group (2R,5S configuration). It is used in combination therapy for the treatment of HIV-1 infection.
Secondary ChEBI IDCHEBI:174911
Last Modified22 February 2017
DownloadsMolfile
FormulaC8H10FN3O3S
Net Charge0
Average Mass247.251
Monoisotopic Mass247.04269
SMILESNc1nc(=O)n([C@@H]2CS[C@H](CO)O2)cc1F
InChIInChI=1S/C8H10FN3O3S/c9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5-,6+/m0/s1
InChIKeyXQSPYNMVSIKCOC-NTSWFWBYSA-N
Wikipedia
Roles Classification
Biological Roles:
antiviral agent  A substance that destroys or inhibits replication of viruses.
antiviral drug  A substance used in the prophylaxis or therapy of virus diseases.
anti-HBV agent  An antiviral agent that destroys or inhibits the replication of the hepatitis B virus.
insulin-sensitizing drug  An agent which overcomes insulin resistance by activation of the peroxisome proliferator activated receptor gamma (PPAR-gamma).
antitubercular agent  A substance that kills or slows the growth of Mycobacterium tuberculosis and is used in the treatment of tuberculosis.
HIV-1 reverse transcriptase inhibitor  An entity which inhibits the activity of HIV-1 reverse transcriptase.
immunosuppressive agent  An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response.
anti-HIV agent  An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus.
Applications:
antiviral drug  A substance used in the prophylaxis or therapy of virus diseases.
antiinfective agent  A substance used in the prophylaxis or therapy of infectious diseases.
insulin-sensitizing drug  An agent which overcomes insulin resistance by activation of the peroxisome proliferator activated receptor gamma (PPAR-gamma).
antitubercular agent  A substance that kills or slows the growth of Mycobacterium tuberculosis and is used in the treatment of tuberculosis.
immunosuppressive agent  An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response.
ChEBI Ontology
Outgoing Relation(s)
emtricitabine (CHEBI:31536) has role anti-HBV agent (CHEBI:64951)
emtricitabine (CHEBI:31536) has role anti-HIV agent (CHEBI:64946)
emtricitabine (CHEBI:31536) has role antiinfective agent (CHEBI:35441)
emtricitabine (CHEBI:31536) has role antitubercular agent (CHEBI:33231)
emtricitabine (CHEBI:31536) has role antiviral agent (CHEBI:22587)
emtricitabine (CHEBI:31536) has role antiviral drug (CHEBI:36044)
emtricitabine (CHEBI:31536) has role HIV-1 reverse transcriptase inhibitor (CHEBI:53756)
emtricitabine (CHEBI:31536) has role immunosuppressive agent (CHEBI:35705)
emtricitabine (CHEBI:31536) has role insulin-sensitizing drug (CHEBI:50864)
emtricitabine (CHEBI:31536) is a monothioacetal (CHEBI:59793)
emtricitabine (CHEBI:31536) is a nucleoside analogue (CHEBI:60783)
emtricitabine (CHEBI:31536) is a organofluorine compound (CHEBI:37143)
emtricitabine (CHEBI:31536) is a pyrimidone (CHEBI:38337)
Incoming Relation(s)
Descovy (CHEBI:133007) has part emtricitabine (CHEBI:31536)
Genvoya (CHEBI:90922) has part emtricitabine (CHEBI:31536)
Odefsey (CHEBI:133010) has part emtricitabine (CHEBI:31536)
IUPAC Name 
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
INN  Source
emtricitabinaWHO MedNet
Synonyms  Source
(−)-2'-deoxy-5-fluoro-3'-thiacytidineChemIDplus
(−)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosineChEBI
(2R-cis)-4-amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinoneChemIDplus
4-Amino-5-fluoro-1-((2R,5S)-2-hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-oneChEMBL
4-amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-oneChEMBL
524-W-91ChEMBL
Brand Names  Source
Emtricitabine component of atriplaChEMBL
Emtricitabine component of biktarvyChEMBL
Emtricitabine component of compleraChEMBL
Emtricitabine component of descovyChEMBL
Emtricitabine component of evipleraChEMBL
Emtricitabine component of genvoyaChEMBL
Manual XrefsDatabases
1003DrugCentral
C12599KEGG COMPOUND
D01199KEGG DRUG
DB00879DrugBank
EmtricitabineWikipedia
ETVPDBeChem
US5538975Patent
WO9214743Patent
Registry NumbersSources
Beilstein:5908714Beilstein
CAS:143491-57-0KEGG COMPOUND
CAS:143491-57-0ChemIDplus
Citations